Ligand to Participate in November Investor Conferences
Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) announced that Chief Executive Officer Todd Davis and Chief Financial Officer Tavo Espinoza will participate in upcoming investor conferences.
- Ligand management will host one-on-one meetings with investors and attendees.
- Investors interested in arranging one-on-one meetings should contact their UBS or Stifel representative.
Ligand is a biopharmaceutical company enabling scientific advancement through supporting the clinical development of high-value medicines.
About Ligand Pharmaceuticals: Ligand provides financing, licensing our technologies or both to support clinical development.
Author summary: Ligand Pharmaceuticals to participate in investor conferences.
More News
- Cineworld announces luxury upgrade at Silverburn with new recliner seats
- MEG takeover vote postponed again over questions about Cenovus-Strathcona side deal
- Freedom Financial Holdings Announces Earnings for Third Quarter of 2025
- 'Thief VR: Legacy of Shadow' Comes to All Major VR Headsets in December, New Gameplay Here
- OpenAI launches Aardvark to detect and patch hidden bugs in code
- Quantum Computing Inc. to Host Third Quarter 2025 Shareholder Call on Friday, November 14, 2025
- Astronomy milestone: Scientists capture first image of two black holes orbiting each other
- Class Intercom to Add Survey & Engagement Functionality Following MindMixer Acquisition
- When skeletons come out of the closet and onto the street - Washington Square News
- Over 580,000 Blood Pressure Medication Bottles Recalled, FDA Reports